APA (7th ed.) Citation

D, S. H., D, S. V., M, R. N., & N, G. (2026). Structural Enablers of Rare Disease Treatment Coverage in Latin America and the Caribbean: Lessons from Emicizumab. Journal of market access & health policy, 14(1), . https://doi.org/10.3390/jmahp14010013

Chicago Style (17th ed.) Citation

D, Sugg Herrera, Sepúlveda Viveros D, Russo Namias M, and Garrido N. "Structural Enablers of Rare Disease Treatment Coverage in Latin America and the Caribbean: Lessons from Emicizumab." Journal of Market Access & Health Policy 14, no. 1 (2026). https://doi.org/10.3390/jmahp14010013.

MLA (9th ed.) Citation

D, Sugg Herrera, et al. "Structural Enablers of Rare Disease Treatment Coverage in Latin America and the Caribbean: Lessons from Emicizumab." Journal of Market Access & Health Policy, vol. 14, no. 1, 2026, https://doi.org/10.3390/jmahp14010013.